vs

Side-by-side financial comparison of CME Group (CME) and Victoria's Secret & Co. (VSCO). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× Victoria's Secret & Co.). CME Group runs the higher net margin — 0.1% vs -2.5%, a 2.6% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 9.3%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -15.9%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Victoria's Secret is an American lingerie, clothing and beauty retailer. Founded in 1977 by Stanford graduate student Roy Raymond and his wife Gaye, the company's five lingerie stores were sold to Les Wexner in 1982. Wexner rapidly expanded into American shopping malls, expanding the company into 350 stores nationally with sales of $1 billion by the early 1990s, when Victoria's Secret became the largest lingerie retailer in the United States.

CME vs VSCO — Head-to-Head

Bigger by revenue
CME
CME
1.3× larger
CME
$1.9B
$1.5B
VSCO
Growing faster (revenue YoY)
CME
CME
+5.2% gap
CME
14.5%
9.3%
VSCO
Higher net margin
CME
CME
2.6% more per $
CME
0.1%
-2.5%
VSCO
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-15.9%
VSCO

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CME
CME
VSCO
VSCO
Revenue
$1.9B
$1.5B
Net Profit
$1.2M
$-37.0M
Gross Margin
36.4%
Operating Margin
0.1%
-1.3%
Net Margin
0.1%
-2.5%
Revenue YoY
14.5%
9.3%
Net Profit YoY
20.7%
33.9%
EPS (diluted)
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
VSCO
VSCO
Q1 26
$1.9B
Q4 25
$1.6B
$1.5B
Q3 25
$1.5B
$1.5B
Q2 25
$1.7B
$1.4B
Q1 25
$1.6B
$2.1B
Q4 24
$1.5B
$1.3B
Q3 24
$1.6B
$1.4B
Q2 24
$1.5B
$1.4B
Net Profit
CME
CME
VSCO
VSCO
Q1 26
$1.2M
Q4 25
$1.2B
$-37.0M
Q3 25
$908.0M
$16.0M
Q2 25
$1.0B
$-2.0M
Q1 25
$956.2M
$193.0M
Q4 24
$874.6M
$-56.0M
Q3 24
$912.8M
$32.0M
Q2 24
$883.2M
$-4.0M
Gross Margin
CME
CME
VSCO
VSCO
Q1 26
Q4 25
36.4%
Q3 25
35.6%
Q2 25
35.0%
Q1 25
38.6%
Q4 24
34.7%
Q3 24
35.4%
Q2 24
36.9%
Operating Margin
CME
CME
VSCO
VSCO
Q1 26
0.1%
Q4 25
61.8%
-1.3%
Q3 25
63.3%
2.8%
Q2 25
66.7%
1.5%
Q1 25
67.5%
12.8%
Q4 24
62.1%
-3.5%
Q3 24
64.6%
4.4%
Q2 24
65.3%
1.9%
Net Margin
CME
CME
VSCO
VSCO
Q1 26
0.1%
Q4 25
71.7%
-2.5%
Q3 25
59.1%
1.1%
Q2 25
60.6%
-0.1%
Q1 25
58.2%
9.2%
Q4 24
57.3%
-4.2%
Q3 24
57.6%
2.3%
Q2 24
57.6%
-0.3%
EPS (diluted)
CME
CME
VSCO
VSCO
Q1 26
Q4 25
$3.24
$-0.46
Q3 25
$2.49
$0.20
Q2 25
$2.81
$-0.02
Q1 25
$2.62
$2.41
Q4 24
$2.40
$-0.71
Q3 24
$2.50
$0.40
Q2 24
$2.42
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
VSCO
VSCO
Cash + ST InvestmentsLiquidity on hand
$2.4B
$249.0M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$653.0M
Total Assets
$202.0B
$5.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
VSCO
VSCO
Q1 26
$2.4B
Q4 25
$4.5B
$249.0M
Q3 25
$2.6B
$188.0M
Q2 25
$2.1B
$138.0M
Q1 25
$1.5B
$227.0M
Q4 24
$3.0B
$161.0M
Q3 24
$2.4B
$169.0M
Q2 24
$1.9B
$105.0M
Total Debt
CME
CME
VSCO
VSCO
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
VSCO
VSCO
Q1 26
Q4 25
$28.7B
$653.0M
Q3 25
$28.2B
$680.0M
Q2 25
$27.7B
$645.0M
Q1 25
$27.0B
$640.0M
Q4 24
$26.5B
$429.0M
Q3 24
$28.2B
$472.0M
Q2 24
$27.6B
$423.0M
Total Assets
CME
CME
VSCO
VSCO
Q1 26
$202.0B
Q4 25
$198.4B
$5.1B
Q3 25
$187.1B
$4.8B
Q2 25
$179.9B
$4.6B
Q1 25
$157.8B
$4.5B
Q4 24
$137.4B
$4.9B
Q3 24
$137.8B
$4.6B
Q2 24
$123.4B
$4.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
VSCO
VSCO
Operating Cash FlowLast quarter
$-180.0M
Free Cash FlowOCF − Capex
$-232.0M
FCF MarginFCF / Revenue
-15.8%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$309.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
VSCO
VSCO
Q1 26
Q4 25
$1.1B
$-180.0M
Q3 25
$968.1M
$156.0M
Q2 25
$1.1B
$-150.0M
Q1 25
$1.1B
$674.0M
Q4 24
$1.0B
$-248.0M
Q3 24
$1.0B
$115.0M
Q2 24
$776.9M
$-116.0M
Free Cash Flow
CME
CME
VSCO
VSCO
Q1 26
Q4 25
$1.1B
$-232.0M
Q3 25
$949.7M
$88.0M
Q2 25
$1.0B
$-193.0M
Q1 25
$1.1B
$646.0M
Q4 24
$991.7M
$-299.0M
Q3 24
$973.2M
$55.0M
Q2 24
$758.7M
$-155.0M
FCF Margin
CME
CME
VSCO
VSCO
Q1 26
Q4 25
66.8%
-15.8%
Q3 25
61.8%
6.0%
Q2 25
61.5%
-14.3%
Q1 25
67.1%
30.7%
Q4 24
65.0%
-22.2%
Q3 24
61.4%
3.9%
Q2 24
49.5%
-11.4%
Capex Intensity
CME
CME
VSCO
VSCO
Q1 26
Q4 25
2.0%
3.5%
Q3 25
1.2%
4.7%
Q2 25
1.1%
3.2%
Q1 25
0.9%
1.3%
Q4 24
1.7%
3.8%
Q3 24
1.9%
4.2%
Q2 24
1.2%
2.9%
Cash Conversion
CME
CME
VSCO
VSCO
Q1 26
Q4 25
0.96×
Q3 25
1.07×
9.75×
Q2 25
1.03×
Q1 25
1.17×
3.49×
Q4 24
1.16×
Q3 24
1.10×
3.59×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

VSCO
VSCO

Sales Channel North America Stores$778.0M53%
Sales Channel Directly To Consumer$429.0M29%
Sales Channel International$265.0M18%
Sales Channel Loyalty And Private Label Credit Card$19.0M1%

Related Comparisons